Adeshwar Meditex Limited announced the reappointment of M/s. Basude Makote & Saini, Chartered Accountants, as its Internal Auditors for the financial years 2025-26 to 2027-28. The decision was taken at a Board of Directors meeting held on May 14, 2026, commencing at 4:00 PM (IST) and concluding at 4:30 PM (IST). The reappointment was made pursuant to Section 138 of the Companies Act, 2013, and the disclosure was submitted to BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Reappointment Details

The following key details of the reappointment were disclosed by the company:

Profile of M/s. Basude Makote & Saini

M/s. Basude Makote & Saini is a well-established Chartered Accountant firm with extensive experience working with corporate entities, LLPs, partnership firms, banks, and co-operatives. The firm offers a broad range of professional services, as highlighted below:

• Statutory Audit and Internal Audit
• Stock Audit and Forensic Audit
• Project Financing
• Direct and Indirect Tax Consultancy
• Due Diligence and Legal Services
• Preparation and Finalization of Balance Sheets for companies, firms, educational institutions, and other organizations
• Reconciliation of Accounts
• Extensive litigation before appeal

The firm is also engaged in rendering legal and due diligence services to various industries and corporates across the country.

Board Authorization

The reappointment was authorized by Krishnojirao Nagaraja Rao, Whole-time Director (DIN: 07684308), on behalf of Adeshwar Meditex Limited. The company noted that there is no disclosure of relationships between directors applicable in this case, as the appointment pertains to an auditing firm and not a director. The outcome of the board meeting was communicated to BSE Limited for record purposes in compliance with applicable regulatory requirements.

Adeshwar meditex Limited has filed its quarterly compliance disclosure with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The disclosure pertains to the quarter ended March 31, 2026, and was submitted on April 8, 2026.

Regulatory Compliance Details

The company submitted the mandatory disclosure under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation requires companies to report on dematerialisation activities during each quarter through their Registrar and Transfer Agent.

Dematerialisation Activity Report

Bigshare Services Pvt. Ltd., serving as the company's Registrar and Transfer Agent, confirmed that no dematerialisation requests for equity shares were received during the reporting period. The certificate was issued on April 5, 2026, and subsequently forwarded to BSE Limited by the company.

The RTA's certificate specifically stated that no dematerialisation requests for equity shares of Adeshwar Meditex Limited were received during the period from January 1, 2026 to March 31, 2026.

Filing Authorization

The disclosure was signed and submitted by Krishnojirao Nagaraja Rao, Director of Adeshwar Meditex Limited, bearing DIN 07684308. The document was digitally signed on April 8, 2026, at 16:08:05 hours.

Company and RTA Information

Adeshwar Meditex Limited is located at 605, 6th Floor, Plot-99, Niranjan Building, Bhagwan Todi Bal Udyan Marg, Marine Lines Railway Station, Marine Drive, Mumbai - 400002. The company works with Bigshare Services Pvt. Ltd. as its Registrar and Transfer Agent, with the RTA's registered office at Office No S6-2, 6th Floor, Pinnacle Business Park, Andheri (East), Mumbai - 400093.

This quarterly filing demonstrates the company's adherence to SEBI's regulatory framework and maintains transparency in share transfer and dematerialisation processes for stakeholders.